Header Logo

Connection

PRASUN JALAL to Humans

Back to Details
This is a "connection" page, showing publications PRASUN JALAL has written about Humans.
PRASUN JALAL
Connection Strength
0.230
Humans
  1. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management. World J Gastroenterol. 2023 Dec 14; 29(46):6028-6048.
    View in: PubMed
    Score: 0.019
  2. Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes. Cancer Med. 2023 07; 12(14):15011-15025.
    View in: PubMed
    Score: 0.018
  3. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018. Cancer Epidemiol Biomarkers Prev. 2022 Dec 05; 31(12):2169-2176.
    View in: PubMed
    Score: 0.017
  4. No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis. J Infect. 2023 02; 86(2):154-225.
    View in: PubMed
    Score: 0.017
  5. Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat? Cancer. 2022 10 01; 128(19):3441-3442.
    View in: PubMed
    Score: 0.017
  6. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Rev Med Virol. 2022 11; 32(6):e2353.
    View in: PubMed
    Score: 0.017
  7. Utility of serum angiopoietin-2 as diagnostic marker of hepatocellular carcinoma: A systematic review and diagnostic test accuracy meta-analysis. Clin Res Hepatol Gastroenterol. 2022 05; 46(5):101909.
    View in: PubMed
    Score: 0.016
  8. Retrospective analysis of long-term outcome 10 years after liver transplantation for Wilson disease: experience over three decades. Transpl Int. 2020 08; 33(8):925-935.
    View in: PubMed
    Score: 0.014
  9. Predicting severe acute pancreatitis: how have we done so far? J Gastroenterol Hepatol. 2007 Mar; 22(3):291-2.
    View in: PubMed
    Score: 0.006
  10. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
    View in: PubMed
    Score: 0.005
  11. Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2024 01; 22(1):72-80.e4.
    View in: PubMed
    Score: 0.005
  12. Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec; 17(7):741-751.
    View in: PubMed
    Score: 0.004
  13. The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
    View in: PubMed
    Score: 0.004
  14. Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3).
    View in: PubMed
    Score: 0.004
  15. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25.
    View in: PubMed
    Score: 0.004
  16. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. J Viral Hepat. 2022 09; 29(9):807-816.
    View in: PubMed
    Score: 0.004
  17. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
    View in: PubMed
    Score: 0.004
  18. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.004
  19. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med. 2021 10; 10(20):7308-7319.
    View in: PubMed
    Score: 0.004
  20. Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA-Based Study. Hepatology. 2021 12; 74(6):3161-3173.
    View in: PubMed
    Score: 0.004
  21. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 11; 75(5):1026-1033.
    View in: PubMed
    Score: 0.004
  22. Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults. Nutrients. 2021 Jun 11; 13(6).
    View in: PubMed
    Score: 0.004
  23. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341.
    View in: PubMed
    Score: 0.004
  24. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020 04 15; 217:103645.
    View in: PubMed
    Score: 0.004
  25. Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. Liver Transpl. 2020 01; 26(1):68-79.
    View in: PubMed
    Score: 0.004
  26. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
    View in: PubMed
    Score: 0.003
  27. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983.
    View in: PubMed
    Score: 0.003
  28. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
    View in: PubMed
    Score: 0.003
  29. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.003
  30. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799.
    View in: PubMed
    Score: 0.003
  31. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014 May 09; 106(5).
    View in: PubMed
    Score: 0.002
  32. Use of a novel transluminal balloon accessotome in transmural drainage of pancreatic pseudocyst (with video). Gastrointest Endosc. 2008 Aug; 68(2):362-5.
    View in: PubMed
    Score: 0.002
  33. Clinical challenges and images in GI. Fasciola hepatica infection and Von Hippel-Lindau disease type 1 with pancreatic and renal involvement. Gastroenterology. 2007 Jan; 132(1):15-6, 467-8.
    View in: PubMed
    Score: 0.001
  34. Gastric heterotopia in the rectum. Gastrointest Endosc. 2006 Jun; 63(7):1075-6; discussion 1076.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.